Label Changes for:
Prevacid (lansoprazole) delayed-release capsules and orally disintegrating tablets
Changes have been made to the PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – May 2010
Use in Specific Populations
- Prevacid is not effective in patients with symptomatic GERD age 1 month to less than 1 year of age
Patient Counseling Information
- Prevacid SoluTab delayed-release orally disintegrating tablets should not be broken or cut